Jump to content

Talk:Enumeral

Page contents not supported in other languages.
From Wikipedia, the free encyclopedia

CorpDepth review of citations

[edit]

This review of the citations associated with the article as of 18 July 2016 does not bode well for retention of the article. As of this date, it would not survive an WP:AfD. --User:Ceyockey (talk to me) 03:06, 19 July 2018 (UTC)[reply]

Source Significant? Independent? Reliable? Secondary pass/fail Cite # Notes
Keown 2018 (Biospace) Y Y Y Y Y
10-Q Y N Y N F This is an excerpt from a republished segment of an SEC quarterly report.
Enumeral PR 2014 Y N Y Y F Significant as it relates completion of merger activity
Nature Biotechnology 2006 N Y Y Y F Not significant with respect to Company information, though likely otherwise significant
Clinical Immunology 2009 N Y Y Y F
PNAS 2008 N Y Y Y F
Lab Chip 2011 N Y Y Y F
J. of Clinical Invest. 2011 N Y Y Y F
Integrative Biology 2013 N Y Y Y F
Nature Immunology 2014 N Y Y Y F
Nature 2014 N Y Y Y F
Nature Biotechnology 2014 N Y Y Y F
Scientific Advisory Board link Y N Y Y F self-published source, likely reliable
Enumeral PR 2015 N N Y Y F Not significant with respect to Company info.
Enumeral PR 2015 N N Y Y F
Enumeral PR 2015 N N Y Y F
Enumeral PR 2015 Y N Y Y F Significant in that relates changes in Advisory Board
Enumeral PR 2014 N N Y Y F Speaks to a collaboration with a major Pharma; significant on its face - but not really unless it has significant impact on the company ... which cannot be said at the start of a collab.
Enumeral PR 2015 N N Y Y F Speaks to meeting a milestone in collab with Merck ... but it doesn't specify the nature of the milestone or the amount of the milestone payment, either of which could have led to Y for significance.
Total qualifying sources 1 There must be multiple qualifying sources to meet the notability requirements